View by Specialty

Trending

Anthony A. Romeo
November 15, 2024
4 min read
Save

Capitalism is the path to value-based care

Spondyloarthropathies News

SPONSORED CONTENT
Save
SPONSORED CONTENT
December 15, 2016
6 min read
Save

What is the Risk of Lymphoma With Treatments?

A:

SPONSORED CONTENT
December 15, 2016
18 min read
Save

Making Use of Precision Medicine for Rheumatic Diseases

Making Use of Precision Medicine for Rheumatic Diseases

The NIH recently commissioned $55 million for studies to investigate precision medicine. While it remains to be seen how many of those dollars will be used in rheumatic diseases, the message is clear: Medicine is moving steadily toward personalized approaches.

Trending

Anthony A. Romeo
November 15, 2024
4 min read
Save

Capitalism is the path to value-based care

SPONSORED CONTENT
December 07, 2016
2 min read
Save

Age has ‘positive impact’ on response to adalimumab for ankylosing spondylitis

Patients with ankylosing spondylitis who are younger, treated sooner after diagnosis and were exposed to fewer NSAIDs demonstrated an improved clinical response to adalimumab, according to findings presented at the American College of Rheumatology Annual Meeting.

SPONSORED CONTENT
December 05, 2016
1 min read
Save

TLIF yielded better outcomes vs PSF for treatment of spondylolisthesis

Investigators of this study found more favorable outcomes in the Oswestry Disability Index for patients with spondylolisthesis who underwent transforaminal lumbar interbody fusion compared with posterolateral spinal fusion; however, this trend was not seen for patients with either spinal stenosis or adjacent segment disease.

SPONSORED CONTENT
November 29, 2016
2 min read
Save

Secukinumab provides sustained efficacy, safety in treatment of psoriatic arthritis

Secukinumab provides sustained efficacy, safety in treatment of psoriatic arthritis

Secukinumab demonstrated continued improvement in the treatment of psoriatic arthritis and was well-tolerated among patients in a 3-year extension of the FUTURE 1 study, according to data presented at the American College of Rheumatology Annual Meeting.

SPONSORED CONTENT
November 29, 2016
2 min read
Save

Statins may decrease mortality in patients with ankylosing spondylitis or psoriatic arthritis

Treatment with statins may reduce mortality risk among patients with ankylosing spondylitis or psoriatic arthritis, according to findings presented during the plenary session at the American College of Rheumatology Annual Meeting.

SPONSORED CONTENT
November 28, 2016
2 min read
Save

Gender has ‘important effect’ on prevalence of extra-articular manifestations in axial spondyloarthropathy

Uveitis and inflammatory bowel disease as extra-articular manifestations of axial spondyloarthropathy appear to be more common in women, according to data presented at the ACR Annual Meeting.

SPONSORED CONTENT
November 21, 2016
1 min read
Save

CVD drugs underused for patients with inflammatory joint disease

CVD drugs underused for patients with inflammatory joint disease

WASHINGTON — Cardiovascular disease-preventing medicines were infrequently used among patients with inflammatory joint disease, according to a study performed by researchers in Norway and presented at the American College of Rheumatology Annual Meeting.

SPONSORED CONTENT
November 18, 2016
4 min read
Save

The Patient With Dry Eyes and Dry Mouth

A 59-year-old woman with a 7-year history of Sjögren’s syndrome, treated symptomatically, has had three episodes of cutaneous vasculitis, successfully treated with oral steroids. She now presents with complaints of a slowly progressive enlargement of her right parotid gland. Her physical exam reveals dry mucous membranes and an enlarged, firm, non-tender right parotid gland.

SPONSORED CONTENT
November 16, 2016
1 min read
Save

Cardiometabolic issues related to inflammatory arthritis highlighted at ACR 2016

Autoimmune disorders such as ankylosing spondylitis, psoriatic arthritis and rheumatoid arthritis not only cause significant pain and disability related to a patient’s joints, but also increase a patient’s risk for other systemic conditions, including cardiovascular disease, that must be monitored and treated.

View more